<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00219947</url>
  </required_header>
  <id_info>
    <org_study_id>MMA-448</org_study_id>
    <nct_id>NCT00219947</nct_id>
  </id_info>
  <brief_title>Viral and Host Factors in the Transmission and Pathogenesis of HIV</brief_title>
  <official_title>Viral and Host Factors in the Transmission and Pathogenesis of HIV</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rockefeller University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rockefeller University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the collection of blood from individuals known to be at high risk for HIV-infection
      or who have been recently infected with HIV.

      The data collected are used for diagnostic, prognostic and management decisions as outlined
      by current HIV-1 Treatment Guidelines.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This phlebotomy protocol permits the collection of blood from individuals known to be at high
      risk for HIV-infection or who have been recently infected with HIV.

      Participants will have from 10 to 60 ml (approximately 1 to 4 tablespoons) of blood drawn for
      one or all of the following tests:

        -  T cell subset enumeration

        -  Serologic reactivity with HIV antigens

        -  Viral load assays by bDNA, PCR, or RT-PCR

        -  Routine Laboratory assessments (chemistries, liver function tests, hepatitis serology,
           RPR)

        -  HIV-1 Resistance Testing

      These data are used for diagnostic, prognostic and management decisions as outlined by
      current HIV-1 Treatment Guidelines
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2000</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Participants are tested for HIV-1 RNA levels, the presence of antibodies to HIV antigens, and T cell subsets</measure>
    <time_frame>first visit</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Data will be used for diagnostic, prognostic and management decisions as outlined by current HIV-1 Treatment</measure>
    <time_frame>first visit</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>high risk</arm_group_label>
    <description>Blood draw from individuals known to be or at high risk for HIV-infection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>diagnosed</arm_group_label>
    <description>Blood draw f rom individuals diagnosed with HIV infection</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood draw</intervention_name>
    <description>T cell subset enumeration
Serologic reactivity with HIV antigens
Viral load assays by bDNA, PCR, or RT-PCR
Routine Laboratory assessments (chemistries, liver function tests, hepatitis serology, RPR)
HIV-1 Resistance Testing</description>
    <arm_group_label>high risk</arm_group_label>
    <arm_group_label>diagnosed</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects are either referred by primary health care providers, self-referred, or may be
        seeking enrollment in other ADARC clinical trials in the NYC area.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        recently infected with HIV-1 HIV-1 negative, and at high risk for infection

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin M Markowitz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rockefeller University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Melissa La Mar</last_name>
    <phone>212-327-7280</phone>
    <email>mlamar@rockefeller.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aaron Diamond AIDS Research Center (ADARC)</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa La Mar</last_name>
      <phone>212-327-7280</phone>
      <email>mlamar@adarc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rockefeller University Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa La Mar</last_name>
      <phone>212-327-7280</phone>
      <email>mlamar@rockefeller.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://clinicalstudies.rucares.org/protocol.php?id=97&amp;cat=20</url>
    <description>Institutional website listing clinical research protocols and criteria</description>
  </link>
  <link>
    <url>http://www.adarc.org</url>
    <description>The Aaron Diamond AIDS Research Center</description>
  </link>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 20, 2005</study_first_submitted>
  <study_first_submitted_qc>September 20, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <last_update_submitted>January 10, 2018</last_update_submitted>
  <last_update_submitted_qc>January 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HIV Infection</keyword>
  <keyword>Acute HIV Infection</keyword>
  <keyword>Primary HIV Infection</keyword>
  <keyword>Acute Seroconversion Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

